# Adaptimmune Therapeutics plc (ADAP) vs State Street SPDR S&P 500 ETF Trust (SPY) · total-return overlay

LOPJLB holding-return compare (5Y). Dividends and splits. Each path starts at 0% from the first adjusted close in the window.

Adaptimmune Therapeutics plc (ADAP) vs State Street SPDR S&P 500 ETF Trust (SPY) total return over 5Y: ADAP -99.01%, SPY +88.08%. Regime ADAP CRISIS · SPY BULL. As of Oct 12, 2026. Research only.

- Interactive: https://www.lopjlb.com/vs/ADAP/SPY
- API: `GET /bff/api/bigfive/compare-series?symbols=ADAP%2CSPY&range=5y`

## Window

| Symbol | Window % | Worst drawdown | YTD |
|---|---:|---:|---:|
| ADAP | -99.01% | -99.28% | -91.36% |
| SPY | +88.08% | -24.49% | +14.79% |

## Periods (calendar lookback)

| Symbol | 1Y | 2Y | 3Y | 5Y |
|---|---:|---:|---:|---:|
| ADAP | -92.69% | -90.29% | -96.12% | — |
| SPY | +18.62% | +36.24% | +86.06% | +88.08% |

## Annual

| Year | ADAP | SPY |
|---|---:|---:|
| YTD | — | +14.79% |
| 2025 | -91.36% | +18.01% |
| 2024 | -27.79% | +25.59% |
| 2023 | -52.51% | +26.73% |
| 2022 | -64.04% | -18.64% |
| 2021 | -31.19% | +7.72% |

---

Research context only. Not personalized investment advice.